Antiproliferative effects of SOM230 in EPN prostate cell line

被引：0
|
作者：
Rossi, V
Pasquali, D
Gazzerro, G
Abbondanza, C
Bellastella, A
Puca, GA
Sinisi, AA
机构：
[1] Univ Naples 2, Dip Internist Clin & Sperimentale, Naples, Italy
[2] Univ Naples 2, Dip Patol Gen, Naples, Italy
来源：
EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2005年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients
    van der Hoek, J
    de Herder, WW
    Feelders, RA
    van der Lely, AJ
    Uitterlinden, P
    Boerlin, V
    Bruns, C
    Poon, KW
    Lewis, I
    Weckbecker, G
    Krahnke, T
    Hofland, LJ
    Lamberts, SW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02): : 638 - 645
  • [42] Tolerability of SOM230, a novel multiligand somatostatin analogue, when given by continuous subcutaneous infusion
    Petersenn, S
    Unger, N
    Glusman, J
    Hosius, C
    Tran, LL
    Mann, K
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152
  • [43] Phase I trial of docetaxel (D), prednisone, and pasireotide (P) (SOM230) in metastatic castrate-resistant prostate cancer (mCRPC).
    Vankayala, Hema M.
    Heilbrun, Lance K.
    Dobson, Kimberlee
    Stark, Karri
    Li, Jing
    Smith, Daryn W.
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease
    Cukier, Kimberly
    Tewari, Reena
    Kurth, Fabian
    Schmid, Herbert A.
    Lai, Clinton
    Torpy, David J.
    CLINICAL ENDOCRINOLOGY, 2009, 71 (02) : 305 - 307
  • [45] The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion
    Murray, RD
    Kim, K
    Ren, SG
    Lewis, I
    Weckbecker, G
    Bruns, C
    Melmed, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 3027 - 3032
  • [46] MEDI 234-New perspectives on the medicinal chemistry of the somatostatin receptor agonist SOM230
    Lewis, Ian
    Albert, Rainer
    Pless, Janos
    Kneuer, Rainer
    Schmid, Herbert A.
    Silva, Antonio P.
    Hoyer, Daniel
    Weckbecker, Gisbert
    Bruns, Christian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [47] EPN: A novel epithelial cell line derived from human prostate tissue
    Sinisi A.A.
    Chieffi P.
    Pasquali D.
    Kisslinger A.
    Staibano S.
    Bellastella A.
    Tramontano D.
    In Vitro Cellular & Developmental Biology - Animal, 2002, 38 (3) : 165 - 172
  • [48] UFC response is related to pasireotide (SOM230) plasma concentrations in patients with Cushing's disease
    Maldonado, Mario
    Boscaro, Marco
    Zhang, Yilong
    Sen, Kapildeb
    Schoenherr, Ulrike
    Findling, James
    ENDOCRINE JOURNAL, 2010, 57 : S514 - S514
  • [49] SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts
    Xie, Yan
    Chen, Shuang
    Wang, Chun-hui
    Tang, Cheng-wei
    CANCER BIOLOGY & THERAPY, 2011, 12 (01) : 86 - 92
  • [50] Pasireotide (SOM230): Mechanism of Action in Acromegaly, Cushing's Disease and GEP-NETs
    Schmid, H. A.
    Silva, A. P.
    van Vugt, H. H.
    Gadelha, M.
    PROCEEDINGS OF THE 13TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2008, : 467 - +
12345